Peripheral artery disease and glaucoma: The Singapore Malay eye study

Archives of Ophthalmology

Volumn 127, Issue 7, 2009, Pages 888-893

  Jeganathan, V Swetha E ^a,d   Wong, Tien Yin ^a,d   Foster, Paul J ^b,c   Crowston, Jonathan G ^a   Tay, Wan Ting ^h   Lim, Su Chi ^e   Saw, Seang Mei ^d   Tai, E Shyong ^d,f   Aung, Tin ^d,g  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c MOORFIELDS EYE HOSPITAL   (United Kingdom)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e ALEXANDRA HOSPITAL   (Singapore)

^f SINGAPORE GENERAL HOSPITAL   (Singapore)

^g SINGAPORE NATIONAL EYE CENTRE   (Singapore)

^h NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; TRIACYLGLYCEROL;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLAUCOMA; HUMAN; HYPERTENSION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; OPTIC DISK CUP; POPULATION RESEARCH; PRIORITY JOURNAL; RISK; SEX DIFFERENCE; SINGAPORE; STATISTICAL ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ANKLE BRACHIAL INDEX; BLOOD PRESSURE; CREATININE; CROSS-SECTIONAL STUDIES; FEMALE; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; ODDS RATIO; PERIMETRY; PERIPHERAL VASCULAR DISEASES; RISK FACTORS; SINGAPORE; TONOMETRY, OCULAR; TRIGLYCERIDES; VISUAL FIELDS;

EID: 67650422674     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2009.136     Document Type: Article

References (52)

1. Omoti AE, Edema OT. A review of the risk factors in primary open angle glaucoma. Niger J Clin Pract. 2007;10(1):79-82.
2. Flammer J, Pache M, Resink T. Vasospasm, its role in the pathogenesis of diseases with particular reference to the eye. Prog Retin Eye Res. 2001;20(3): 319-349.
3. Sugiyama DT, Townsend JC, Bright DC, Ilsen PF. Support for the vasogenic theory of glaucoma: case reports and literature review. J Am Optom Assoc. 1993; 64(8):568-582.
4. Gherghel D, Hosking SL, Armstrong R, Cunliffe IA. Autonomic dysfunction in unselected and untreated primary open angle glaucoma patients: a pilot study. Ophthalmic Physiol Opt. 2007;27(4):336-341.
5. Lyons-Wait VA, Anderson SF, Townsend JC, De Land P. Ocular and systemic findings and their correlation with hemodynamically significant carotid artery stenosis: a retrospective study. Optom Vis Sci. 2002;79(6):353-362.
6. Emre M, Orgul S, Gugleta K, Flammer J. Ocular blood flow alteration in glaucoma is related to systemic vascular dysregulation. Br J Ophthalmol. 2004; 88(5):662-666.
7. Su WW, Cheng ST, Ho WJ, Tsay PK, Wu SC, Chang SH. Glaucoma is associated with peripheral vascular endothelial dysfunction. Ophthalmology. 2008;115 (7):1173-1178, e1.
8. Brown CM, Dütsch M, Michelson G, Neundörfer B, Hilz MJ. Impaired cardiovascular responses to baroreflex stimulation in open-angle and normal-pressure glaucoma. Clin Sci (Lond). 2002;102(6):623-630.
9. Tielsch JM, Katz J, Sommer A, Quigley HA, Javitt JC. Hypertension, perfusion pressure, and primary open-angle glaucoma: a population-based assessment. Arch Ophthalmol. 1995;113(2):216-221.
10. Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, Yang Z; EMGT Group. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology. 2007;114(11):1965-1972.
11. Leske MC, Wu SY, Hennis A, Honkanen R, Nemesure B; BESs Study Group. Risk factors for incident open-angle glaucoma: the Barbados Eye Studies. Ophthalmology. 2008;115(1):85-93.
12. de Voogd S, Wolfs RCW, Jansonius NM, Witteman JCM, Hofman A, de Jong PTVM. Atherosclerosis, C-reactive protein, and risk for open-angle glaucoma: the Rotterdam study. Invest Ophthalmol Vis Sci. 2006;47(9):3772-3776.
13. Davies JR, Rudd JH, Weissberg PL. Molecular and metabolic imaging of atherosclerosis. J Nucl Med. 2004;45(11):1898-1907.
14. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation. 2004;110(6):738-743.
15. Whiteman MC, Deary IJ, Lee AJ, Fowkes FG. Submissiveness and protection from coronary heart disease in the general population: Edinburgh Artery Study. Lancet. 1997;350(9077):541-545.
16. Fowkes FG, Housley E, Riemersma RA, et al. Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study. Am J Epidemiol. 1992;135(4):331-340.
17. Foong AWP, Saw S-M, Loo J-L, et al. Rationale and methodology for a population-based study of eye diseases in Malay people: the Singapore Malay Eye Study (SiMES). Ophthalmic Epidemiol. 2007;14(1):25-35.
18. Wong TYCE, Wong WL, Loo JL, et al; Singapore Malay Eye Study Team. Prevalence and causes of low vision and blindness in an urban Malay population: the Singapore Malay Eye Study. Arch Ophthalmol. 2008;126(8):1091-1099.
19. Amerasinghe N, Wong TY, Wong WL, et al; SiMES Study Group. Determinants of optic cup to disc ratio in an Asian population: the Singapore Malay Eye Study (SiMES). Arch Ophthalmol. 2008;126(8):1101-1108.
20. Foster PJ, Oen FT, Machin D, et al. The prevalence of glaucoma in Chinese residents of Singapore: a cross-sectional population survey of the Tanjong Pagar district. Arch Ophthalmol. 2000;118(8):1105-1111.
21. Foster PJ, Buhrmann R, Quigley HA, Johnson GJ. The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol. 2002;86(2):238-242.
22. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286(11):1317-1324.
23. Feringa HH, Karagiannis SE, Schouten O, et al. Prognostic significance of declining ankle-brachial index values in patients with suspected or known peripheral arterial disease. Eur J Vasc Endovasc Surg. 2007;34(2):206-213.
24. Feringa HHH, Bax JJJ, van Waning VH, et al. The long-term prognostic value of the resting and postexercise ankle-brachial index. Arch Intern Med. 2006;166 (5):529-535.
25. Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med. 2001;344(21):1608-1621.
26. Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol. 1991;20(2): 384-392.
27. Schroll M, Munck O. Estimation of peripheral arteriosclerotic disease by ankle blood pressure measurements in a population study of 60-year-old men and women. J Chronic Dis. 1981;34(6):261-269.
28. Ouriel K, McDonnell AE, Metz CE, Zarins CK. Critical evaluation of stress testing in the diagnosis of peripheral vascular disease. Surgery. 1982;91(6):686-693.
29. Mohler ER III. Peripheral arterial disease: identification and implications. Arch Intern Med. 2003;163(19):2306-2314.
30. Gasser P. Why study vascular factors in glaucoma? Int Ophthalmol. 1998-1999; 22(4):221-225.
31. Tezel G, Wax MB. The immune system and glaucoma. Curr Opin Ophthalmol. 2004;15(2):80-84.
32. Tang S, Toda Y, Kashiwagi K, et al. The association between Japanese primary open-angle glaucoma and normal tension glaucoma patients and the optineurin gene. Hum Genet. 2003;113(3):276-279.
33. Tezel G, Wax MB. Hypoxia-inducible factor 1alpha in the glaucomatous retina and optic nerve head. Arch Ophthalmol. 2004;122(9):1348-1356.
34. Hayreh SS. Retinal and optic nerve head ischemic disorders and atherosclerosis: role of serotonin. Prog Retin Eye Res. 1999;18(2):191-221.
35. Zeitz O, Galambos P, Wagenfeld L, et al. Glaucoma progression is associated with decreased blood flow velocities in the short posterior ciliary artery. Br J Ophthalmol. 2006;90(10):1245-1248.
36. Galassi F, Sodi A, Ucci F, Renieri G, Pieri B, Baccini M. Ocular hemodynamics and glaucoma prognosis: a color Doppler imaging study. Arch Ophthalmol. 2003; 121(12):1711-1715.
37. Haufschild T, Shaw SG, Kesselring J, Flammer J. Increased endothelin-1 plasma levels in patients with multiple sclerosis. J Neuroophthalmol. 2001;21(1):37-38.
38. Pache M, Kaiser HJ, Akhalbedashvili N, et al. Extraocular blood flow and endothelin-1 plasma levels in patients with multiple sclerosis. Eur Neurol. 2003; 49(3):164-168.
39. Signorelli SS, Mazzarino MC, Spandidos DA, Malaponte G. Proinflammatory circulating molecules in peripheral arterial disease. Int J Mol Med. 2007;20(3): 279-286.
40. Kahn HA, Milton RC. Revised Framingham eye study prevalence of glaucoma and diabetic retinopathy. Am J Epidemiol. 1980;111(6):769-776.
41. Dielemans I, de Jong PT, Stolk R, Vingerling JR, Grobbee DE, Hofman A. Primary open-angle glaucoma, intraocular pressure, and diabetes mellitus in the general elderly population: the Rotterdam Study. Ophthalmology. 1996;103 (8):1271-1275.
42. Mitchell P, Smith W, Chey T, Healey PR. Open-angle glaucoma and diabetes: the Blue Mountains Eye Study, Australia. Ophthalmology. 1997;104(4):712-718.
43. Hennis A, Wu SY, Nemesure B, Leske MC; Barbados Eye Studies Group. Hypertension, diabetes, and longitudinal changes in intraocular pressure. Ophthalmology. 2003;110(5):908-914.
44. Tielsch JM, Katz J, Quigley HA, Javitt JC, Sommer A. Diabetes, intraocular pressure, and primary open-angle glaucoma in the Baltimore Eye Survey. Ophthalmology. 1995;102(1):48-53.
45. Vijaya L, George R, Paul PG, et al. Prevalence of open-angle glaucoma in a rural south Indian population. Invest Ophthalmol Vis Sci. 2005;46(12):4461-4467.
46. Kahn HA, Milton RC. Alternative definitions of open-angle glaucoma: effect on prevalence and associations in the Framingham eye study. Arch Ophthalmol. 1980; 98(12):2172-2177.
47. Bengtsson B. The prevalence of glaucoma. Br J Ophthalmol. 1981;65(1):46-49.
48. Piltz-seymour JR, Grunwald JE, Hariprasad SM, Dupont J. Optic nerve blood flow is diminished in eyes of primary open-angle glaucoma suspects. Am J Ophthalmol. 2001;132(1):63-69.
49. Grunwald JE, Riva CE, Stone RA, Keates EU, Petrig BL. Retinal autoregulation in open-angle glaucoma. Ophthalmology. 1984;91(12):1690-1694.
50. Nakamura M, Kanamori A, Negi A. Diabetes mellitus as a risk factor for glaucomatous optic neuropathy. Ophthalmologica. 2005;219(1):1-10.
51. Jacobson DR, Murphy RP, Rosenthal AR. The treatment of angle neovascularization with panretinal photocoagulation. Ophthalmology. 1979;86(7):1270-1277.
52. Zeiter JH, Shin DH, Baek NH. Visual field defects in diabetic patients with primary open-angle glaucoma. Am J Ophthalmol. 1991;111(5):581-584.